Related Experiment Video
Updated: Mar 29, 2026
08:16
Noninvasive Monitoring of Lesion Size in a Heterologous Mouse Model of Endometriosis
Published on: February 26, 2019
8.9K
Innovations in classical hormonal targets for endometriosis
Nicola Pluchino1, Letizia Freschi2, Jean-Marie Wenger1
1a Division of Obstetrics and Gynecology , University Hospital of Geneva , Geneva , Switzerland.
Expert Review of Clinical Pharmacology
|December 10, 2015
Summary
Endometriosis, affecting 10% of women, involves hormonal imbalances like estrogen and progesterone resistance. New therapeutic strategies target these hormonal mechanisms for improved long-term management.
Area of Science:
- Gynecology
- Endocrinology
- Cell Biology
Background:
- Endometriosis is a chronic gynecological condition affecting 10% of women of reproductive age.
- Disease etiology is unknown but linked to hormonal imbalances, including estrogen and progesterone.
- These imbalances promote endometrial cell proliferation, migration, and inflammation, leading to pain and infertility.
Purpose of the Study:
- To provide an overview of therapeutic strategies for endometriosis.
- To highlight innovations in targeting classical hormonal mechanisms involved in lesion development.
- To discuss the development of new molecules for endometriosis treatment.
Main Methods:
- Review of current literature on endometriosis pathophysiology and treatment.
- Analysis of hormonal pathways (estrogen, progesterone) implicated in disease development.
- Discussion of emerging therapeutic targets and novel drug development.
Main Results:
- Hormonal imbalance, particularly involving estrogen and progesterone, is central to endometriosis.
- Current treatments focus on modulating these hormonal pathways.
- New therapeutic strategies are being developed to target these mechanisms more effectively.
Conclusions:
- Hormonal imbalance in endometriosis presents a viable target for therapeutic intervention.
- Innovations in targeting estrogen and progesterone pathways offer promise for improved treatments.
- Careful consideration of additional biological targets is necessary for long-term management of endometriosis.
Related Concept Videos
01:30Hormonal Control of the Ovarian Cycle
7.6K
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
7.6K
01:22Hormonal Regulation of the Menstrual Cycle
2.3K
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
2.3K
01:21Intrauterine Drug Delivery Systems
127
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
127
01:22Target Cell Response to Hormones
6.2K
Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
6.2K